Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 115Brain Neoplasms 114Prostatic Neoplasms 101Neoplasm Metastasis 79Carcinoma, Hepatocellular 69Lung Neoplasms 67Pancreatic Neoplasms 64Breast Neoplasms 48Melanoma 37Carcinoma, Renal Cell 33Neoplasms 31Squamous Cell Carcinoma of Head and Neck 21Colorectal Neoplasms 20Liver Neoplasms 19Glioblastoma 18Small Cell Lung Carcinoma 14Head and Neck Neoplasms 14Sarcoma 11Kidney Neoplasms 11Glioma 10Recurrence 8Urinary Bladder Neoplasms 7Radiation Injuries 6Neuroma, Acoustic 6Cholangiocarcinoma 6Adenocarcinoma 6Uveal Melanoma 5Uterine Cervical Neoplasms 5Prostate Cancer Metastatic 5Ovarian Neoplasms 5

Interventions

Gemcitabine 4Radiosurgery 2Electroporation 2130-nm albumin-bound paclitaxel 2zimberelimab 1surufatinib 1Tomography, X-Ray Computed 1S 1 (combination) 1Pancreatectomy 1Oxaliplatin 1Leucovorin 1Immunotherapy 1Heavy Ion Radiotherapy 1Fluorouracil 1Endoscopy 1Drug Therapy 1Diagnostic Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Locally Advanced Pancreatic Cancer × Radiosurgery × Clear all
NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Peking University Third Hospital

Phase 2 Not yet recruiting
96 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT03648632 2022-04-20

SBRT-PC-01

Odense University Hospital

Phase NA Completed
32 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡